Consensus Cloud Solutions, Inc.

Consensus Cloud Solutions, Inc. (CCSI) Market Cap

Consensus Cloud Solutions, Inc. has a market capitalization of .

No quote data available.

CEO: R. Scott Turicchi

Sector: Technology

Industry: Software - Infrastructure

IPO Date: 2021-09-30

Website: https://www.consensus.com

Consensus Cloud Solutions, Inc. (CCSI) - Company Information

Market Cap: -|Sector: Technology

Company Profile

Consensus Cloud Solutions, Inc. operates globally, delivering essential information services through its proprietary software-as-a-service (SaaS) platform. The company offers a comprehensive array of digital communication and data management tools. Its prominent eFax service, alongside related brands such as MyFax and MetroFax, facilitates online faxing for individuals and businesses. For corporate clients, eFax Corporate provides advanced digital cloud-fax technology. Beyond fax, Consensus Cloud Solutions offers jsign, a robust solution for electronic and digital signatures. In the healthcare sector, the company provides several specialized platforms: Unite acts as a unified hub for transmitting and receiving healthcare information, supporting various protocols. It can seamlessly integrate with existing electronic health record (EHR) systems or function independently. Signal integrates with hospital EHR systems, leveraging rules-based logic to automatically generate and send admit, discharge, and transfer (ADT) notifications via cloud fax and secure direct messaging. Clarity is designed to transform complex, unstructured documents into structured, actionable data. These diverse solutions serve a broad range of industries, including healthcare, education, legal, and financial services. Consensus Cloud Solutions, Inc. was founded in 2021 and maintains its headquarters in Los Angeles, California.

Analyst Sentiment

83%
Strong Buy

From 4 Active Polls

1Y Forecast: $25.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$20

Median

$25

High Bound

$30

Average

$25

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$25.00
▼ -31.32% Upside
Low Target
$20.00
-45% Risk
Median Target
$25.00
-31% Mid
High Target
$30.00
-18% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CONSENSUS CLOUD SOLUTIONS INC (CCSI) — Investment Overview

🧩 Business Model Overview

CONSENSUS CLOUD SOLUTIONS INC (CCSI) delivers cloud-based software solutions to healthcare organizations, centered on workflow and operational capabilities that support clinical and administrative activities. The company typically monetizes through a hosted platform that customers deploy to standardize processes, manage data, and improve operational performance.

From a value-chain perspective, CCSI generally participates on the “software layer” of healthcare digitization: it builds and maintains the cloud platform, enables integrations with existing healthcare systems, and supports customers through implementation and ongoing configuration. Once a solution is embedded into daily workflows, it tends to become intertwined with the customer’s operational processes and data flows—creating durable customer stickiness.

💰 Revenue Streams & Monetisation Model

CCSI’s monetisation is primarily driven by recurring subscription revenue tied to customer usage and platform access, supplemented by non-recurring or lower-frequency revenue from implementation, integration, and related services. This mix generally supports a software-like margin structure: software revenue tends to carry higher gross margins than services, while services contribute to initial customer adoption and expansion.

Key margin drivers include: (1) the proportion of revenue coming from subscription/recurring arrangements versus implementation efforts, (2) the efficiency of onboarding and integration workflows, and (3) cost discipline in cloud infrastructure and customer support as the customer base scales.

🧠 Competitive Advantages & Market Positioning

CCSI’s moat is best characterized as high switching costs and intangible asset value in a regulated, integration-heavy environment. In healthcare IT, switching is difficult because the platform becomes embedded in operational processes, requires data migration and re-integration, and must maintain compliance with security and privacy requirements. Over time, “data gravity” and workflow familiarity increase the effective cost of change.

Network effects are typically less central in this category because buyers are not building a multi-sided marketplace around the software. Competitive differentiation instead comes from implementation depth, integration capability, reliability, and domain knowledge.

  • Switching Costs / Data Gravity: Once configured and integrated into customer workflows, replacing the platform involves operational disruption, retraining, and re-building system interfaces.
  • Intangible Assets: Accumulated implementation know-how, customer-specific configurations, and domain expertise in healthcare processes create performance advantages that competitors must replicate.

COMPETITIVE BENCHMARKING:

CCSI competes against established healthcare technology providers that offer overlapping workflow or operational platform capabilities, such as:

  • athenahealth (practice and operational workflow software)
  • Epic Systems (broad enterprise healthcare software ecosystem)
  • Change Healthcare (healthcare data and operational services)

Compared with these rivals, CCSI’s industry focus centers on delivering a cloud platform with strong integration into healthcare workflows, where its practical differentiation relies on implementation depth and customer-specific adoption rather than pure breadth of an enterprise suite.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, CCSI’s growth outlook is supported by secular drivers that expand the total addressable market for cloud-based healthcare software and incentivize workflow modernization:

  • Cloud migration and modernization: Continued replacement of on-premise systems with hosted platforms that improve scalability and deployment speed.
  • Operational efficiency demands: Healthcare organizations face persistent cost and productivity pressure, increasing interest in workflow standardization and automation.
  • Data interoperability and integration needs: As systems evolve, customers seek platforms that integrate reliably with existing environments.
  • Regulatory and compliance acceleration: Ongoing security and privacy requirements favor vendors that can maintain mature, controlled cloud operations.

Because switching costs rise as integrations and processes become embedded, successful adoption can translate into durable revenue retention and expansion, provided CCSI maintains platform reliability and implementation quality.

⚠ Risk Factors to Monitor

  • Regulatory and compliance risk: Healthcare software is subject to stringent privacy/security obligations; any compliance lapse or security incident can materially impact operations and customer trust.
  • Integration and implementation execution risk: Customer onboarding can be complex; delays or underperformance in deployments can affect retention and expansion.
  • Competitive pressure and pricing dynamics: Large incumbents and well-capitalized platforms can pressure customer budgets, increasing the risk of slower net expansion.
  • Technological disruption: Advances in healthcare data platforms and workflow automation (including AI-enabled capabilities) may require sustained product investment to remain competitive.
  • Concentration and demand-cycle risk: Healthcare IT spending can be influenced by reimbursement, budgets, and procurement cycles.

📊 Valuation & Market View

Equity markets typically value healthcare software and SaaS operators using a framework that emphasizes recurring revenue durability and growth visibility, commonly expressed through EV/Revenue, EV/ARR, or P/S rather than earnings-based multiples alone.

Key valuation drivers include: subscription mix and its sustainability, customer retention and net expansion, implementation efficiency, and evidence of scalable unit economics (particularly the ability to grow software revenue without proportionate increases in support and infrastructure costs).

🔍 Investment Takeaway

CCSI’s long-term investment case rests on a healthcare IT model where integration-driven switching costs and accumulated implementation/intangible assets can support durable customer relationships. While competitive and execution risks remain meaningful, the structural demand for cloud modernization and operational efficiency provides a constructive backdrop for multi-year growth—assuming CCSI sustains platform reliability, integration capability, and disciplined scaling of its recurring revenue base.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"CCSI reported Q1’26 revenue of $88.5M and net income of $24.7M, with diluted EPS of $1.30. QoQ, revenue rose modestly (+1.6% vs Q4’25) and net income increased (+20.4% vs Q4’25). YoY, revenue was up slightly (+1.5% vs Q1’25) while net income increased (+16.7% vs Q1’25), indicating improved operating efficiency. Profitability improved across the quarter: gross margin expanded to 80.9% (from 80.0% in Q4’25) and net margin rose to 27.9% (from 23.5%). Operating margin also strengthened to 42.7% (from 41.1%), supported by lower interest expense impact and steadier opex. Cash flow quality was solid. Operating cash flow was $45.8M and free cash flow was $38.5M in Q1’26. The company repurchased shares (-$17.0M) and did not pay dividends. Balance sheet resilience improved materially in Q1’26: cash increased to $92.3M, total assets rose to $678.7M, and equity turned positive at $22.0M (from $13.8M in Q4’25), with net debt improving to -$83.1M (net cash). Total shareholder returns appear strong given a +47.0% 1-year price change; dividends are zero, so performance is largely capital appreciation driven by fundamentals and buybacks."

Revenue Growth

Positive

Revenue growth is modest but positive: +1.5% YoY (Q1’26 vs Q1’25) and +1.6% QoQ (vs Q4’25), suggesting stable demand rather than acceleration.

Profitability

Strong

Margins improved meaningfully: gross margin 80.9% (Q1’26) vs 80.0% (Q4’25) and net margin 27.9% vs 23.5%. Net income up +16.7% YoY and +20.4% QoQ, with EPS rising to $1.30 diluted.

Cash Flow Quality

Good

Operating cash flow was $45.8M and free cash flow $38.5M in Q1’26, supporting repurchases (-$17.0M). No dividends to pressure cash.

Leverage & Balance Sheet

Good

Balance sheet strength improved: cash increased to $92.3M and equity is positive at $22.0M (vs $13.8M in Q4’25). Net debt is -$83.1M (net cash), indicating strong resilience.

Shareholder Returns

Good

Strong capital appreciation with +47.0% 1Y price change. Buybacks were active in the quarter (-$17.0M), while dividend yield is 0%.

Analyst Sentiment & Valuation

Positive

Consensus target of $25 vs current price ~$27.57 implies valuation modestly above consensus. Multiples remain low single-digit on EV/earnings measures (e.g., P/E ~4.5 in Q1’26 ratios), but the provided price-to-book is high due to prior equity volatility.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Consensus delivered a modest consolidated revenue gain (+1.5% YoY) but meaningful quality improvement in Corporate: $58.7M (+8.2% YoY) and net revenue retention of 102% (+76 bps sequentially), signaling expanding enterprise usage and stronger value extraction. Cash generation remained robust with $38.5M free cash flow (+14% YoY), enabling continued buybacks (600,000 shares for ~$17M) while maintaining ample liquidity ($92.3M cash). Profitability held steady with adjusted EBITDA margin at 54.1%, though management attributed Q1 margin support partly to a hiring timing gap versus budget; closing the gap should normalize margins toward the 50%–55% midpoint. SoHo remains a disciplined cash engine with revenue still down (-9.5% YoY), but the decline improved versus Q4 (-11.1%). Guidance was reaffirmed rather than raised; management framed this as early-year prudence rather than conservatism, with planned hiring ramp affecting cadence into 2027.

AI IconGrowth Catalysts

  • Record Corporate channel revenue driven by customer acquisition momentum (8.2% YoY Corporate growth; strongest since Q4 2022)
  • Soft launch of a rearchitected eFax platform for Corporate and SoHo, intended to enable Clarity AI monetization framework via continuous deployment
  • Utilization tailwind from largest enterprise clients routing increasingly uninterrupted data flows through the network
  • Embedded workflow dependency via native integration into major EHR vendor platforms

Business Development

  • Native integration into major EHR vendor platforms (named as a partnership type, not by company)
  • FedRAMP high-certified ECFax solution gaining traction in the public sector
  • VA engagement continuing to scale toward projected 2026 revenue contribution of $9 million

AI IconFinancial Highlights

  • Consolidated revenue: $88.5M, +1.5% YoY (+$1.3M) and +1.6% sequentially; fourth consecutive quarter of YoY revenue growth
  • Adjusted EBITDA: $47.9M vs $47.3M prior year; margin 54.1% consistent YoY
  • Adjusted EPS: $1.52, +10.9% YoY (+$0.15) driven by favorable items and lower share count
  • Non-GAAP tax rate: 20.5% (vs not provided for prior period); share count ~19M
  • Corporate channel: $58.7M revenue, +8.2% YoY (+$4.4M); highest YoY growth since Q4 2022
  • Corporate NRR: 102%, +76 bps sequentially vs Q4 2025; ~100 bps higher vs same period last year; NRR exceedance above 100% target
  • SoHo channel: $29.7M revenue, -9.5% YoY; decline improved from -11.1% in Q4 2025
  • Free cash flow: $38.5M; +14% YoY (+$4.7M)
  • Gross margin bridge described indirectly: adjusted EBITDA margin consistency attributed partly to timing of hiring vs budget

AI IconCapital Funding

  • Repurchased ~600,000 shares in Q1 2026 for approximately $17M
  • Equity repurchases to date: $72M used to repurchase 2.7M shares; $28M remaining under $100M board authorization
  • Cash: $92.3M at quarter end (+$17.6M vs Q4 2025)
  • Q1 2026 CapEx: $7.4M (in line with prior year/expectations)
  • Total debt: ~$560M (6.5% high-yield notes $348M; delayed draw term loan $148M; revolver $64M)
  • Net debt-to-EBITDA: 2.5x; total debt-to-EBITDA: 3x (held steady vs Q4 2025)
  • No substantial debt maturities until late 2028; management monitoring bank/debt markets for opportunistic refinancing before late 2027

AI IconStrategy & Ops

  • Hiring gap vs budget in Q1 supported EBITDA margin; management expects to close gap over the year, moving margins toward the midpoint of the 50%–55% range
  • Updated go-to-market approach: intent-driven customer acquisition at major industry conferences to increase deal volume
  • Management intent: Corporate growth path to double-digit Corporate growth (implied by ongoing compounding momentum)
  • SoHo managed as a Strategic Cash Engine prioritizing yield, efficiency, and contribution margin rather than subscriber longevity

AI IconMarket Outlook

  • Full-year 2026 reaffirmed guidance: Revenue $350M–$364M (midpoint $357M); Adjusted EBITDA $182M–$193M (midpoint $187.5M); Adjusted EPS $5.55–$5.95 (midpoint $5.75)
  • Full-year 2026 income tax rate guidance: 19.7%–21.7% (midpoint 20.7%); ~19M shares
  • Q2 2026 guidance: Revenue $87.9M–$91.9M (midpoint $89.9M); Adjusted EBITDA $46.4M–$49.6M (midpoint $48.0M); Adjusted EPS $1.43–$1.53 (midpoint $1.48M)
  • Q2 2026 tax rate: 19.7%–21.7% (midpoint 20.7%); expected share count ~19M
  • Timing note: Q2 results expected released in the first ~10 days of August; 10-Q to be filed by evening/tomorrow morning

AI IconRisks & Headwinds

  • SoHo revenue continued managed decline (-9.5% YoY), albeit improving vs prior quarter (-11.1%)
  • Adjusted EBITDA margin consistency partially driven by timing of hiring below budget; closing the hiring gap is expected to pressure margins toward the midpoint
  • Guidance positioned as early-year philosophy; management indicated it is “too early” to raise ranges despite positive Q1 movement
  • Hiring and product/engineering ramp may shift revenue contribution into 2027 rather than impacting 2026 immediately

Q&A: Analyst Interest

  • Topic: Reaffirmed 2026 guidance not raised; revenue/earnings cadence. Management said it’s guidance-construction philosophy, not conservatism, and noted Q1 upside flowed to the bottom line while hiring lagged budget. They expect hiring to ramp from early Q2 to support margin and setup for 2027.

Sentiment: MIXED

Note: This summary was synthesized by AI from the CCSI Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Consensus Cloud Solutions, Inc. (CCSI) Financial Profile